Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

ETR/MAK stock hub

ETR/MAK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/MAKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
21.4M
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/MAK
In the news

Latest news · ETR/MAK

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROEn/a
P25 -6.7P50 8.5P75 17.2
ROIC-8.1
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/MAK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
192
Groups with data
11
Currency
EUR
Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Germany
Country code
DE
Employees
1,591
Enterprise value
EUR 19M
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Care Facilities
Isin
DE0006044001
Last refreshed
2026-05-10
Market cap
EUR 21.4M
Price
EUR 1.02
Price currency
EUR
Rev Per Employee
78,932.12x
Sector
Healthcare
Sic
8051
Symbol
etr/MAK
Website
https://www.maternus.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-64.76%
EV Earnings
-1.37x
EV/EBITDA
4.9x
EV/FCF
1.7x
EV/Sales
0.15x
FCF yield
52.18%
P/B ratio
-0.27x
P/S ratio
0.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-3.93%
EBITDA Margin
3.09%
FCF margin
8.89%
Gross margin
24.36%
Gross Profit
EUR 30.6M
Gross Profit Growth
8.39%
Gross Profit Growth Q
14.91%
Gross Profit Growth3 Y
45.16%
Gross Profit Growth5 Y
8.05%
Net Income
EUR -13.9M
Net Income Growth Years
1%
Pretax Margin
-10.25%
Profit Margin
-11.03%
Profit Per Employee
EUR -8,706
ROA
-2.13
Roa5y
-1.79
ROCE
-8.84
ROIC
-8.13
Roic5y
-6.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
-3.75%
Cagr15y
0.2%
Cagr1y
-33.78%
Cagr20y
-2.8%
Cagr3y
-15.82%
Cagr5y
-24.07%
EPS Growth Years
1
FCF Growth
-25.41%
FCF Growth Q
-39.39%
FCF Growth5 Y
33.23%
OCF Growth
-46.97%
OCF Growth Q
-41.09%
OCF Growth10 Y
4.01%
OCF Growth3 Y
57.66%
OCF Growth5 Y
17.97%
Revenue Growth
6.87x
Revenue Growth Q
3.8x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
4.33x
Revenue Growth5 Y
1.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
EUR 0.87
Assets
EUR 149.9M
Cash
EUR 3.9M
Current Assets
EUR 17.6M
Current Liabilities
EUR 80.5M
Equity
EUR -79.1M
Interest Coverage
-0.62
Liabilities
EUR 229M
Long Term Assets
EUR 132.3M
Long Term Liabilities
EUR 148.4M
Net Cash
EUR 3.9M
Net Cash By Market Cap
EUR 18.08
Net Debt EBITDA
EUR -1
Net Debt FCF
EUR -0.35
Tangible Book Value
EUR -93.8M
WACC
4.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.21
Inventory Turnover
232.8
Net Working Capital
EUR -78.3M
Quick ratio
0.15
Working Capital
EUR -74.4M
Working Capital Turnover
EUR -2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-2.36%
Dividend per share
EUR 0
Last Dividend
EUR 0.38

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
-31.73%
1Y total return
-33.77%
200-day SMA
1.1
3Y total return
-40.35%
50-day SMA
1.14
50-day SMA vs 200-day SMA
50over200
5Y total return
-74.75%
All Time High
21.87
All Time High Change
-95.34%
All Time High Date
1996-11-15
All Time Low
0.28
All Time Low Change
262.99%
All Time Low Date
2014-11-07
ATR
0.16
Beta
0.09
Beta1y
0.49
Beta2y
0.84
High
1.02
High52
10.9
High52 Date
2026-03-23
High52ch
-90.64%
Low
0.98
Low52
0.89
Low52 Date
2026-03-19
Low52ch
15.25%
Ma50ch
-10.21%
Price vs 200-day SMA
-7.19%
RSI
45.8
RSI Monthly
36.28
RSI Weekly
46.72
Sharpe ratio
0.57x
Sortino ratio
2.91
Total Return
-2.36%
Tr15y
3.03%
Tr1m
-10.53%
Tr1w
-4.67%
Tr3m
7.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR -4.9M
Operating Income Growth Q
10.42
Operating margin
-3.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,806,876%
Net Borrowing
-7,004,000
Shares Insiders
0.15%
Shares Out
20,970,000
Shares Qo Q
-1.91%
Shares Yo Y
2.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 11.2M
Average Volume
1,005.7x
CAPEX
EUR -2.9M
Ch10y
-31.73
Ch15y
3.03
Ch1m
-10.53
Ch1w
-4.67
Ch1y
-33.77
Ch20y
-43.33
Ch3m
7.37
Ch3y
-40.35
Ch5y
-74.75
Ch6m
-2.86
Change
0%
Change From Open
4.08
Close
1.02
Days Gap
-3.92
Depreciation Amortization
2,635,000
Dollar Volume
7.14
Earnings Date
2026-04-30
EBIT
EUR -4.9M
EBITDA
EUR 3.9M
F Score
5
FCF
EUR 11.2M
FCF EV Yield
58.75x
FCF Per Share
EUR 0.53
Financing CF
-10,170,000
Fiscal Year End
December
Founded
1,877
Income Tax
EUR 1.1M
Investing CF
-2,868,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2025-06-30
Last Split Date
1996-10-01
Last Split Type
Forward
Ma150
1.06
Ma150ch
-4.14%
Ma20
1.09
Ma20ch
-6.76%
Net CF
992,000
Next Earnings Date
2026-06-01
Open
0.98
P FCF Ratio
1.92
P OCF Ratio
1.52
Position In Range
100
Ppne
106,029,000
Price Date
2026-05-08
Price EBITDA
EUR 5.51
Relative Volume
0x
Revenue
125,581,000x
Tax By Revenue
0.87x
Tr20y
-43.33%
Tr6m
-2.86%
Volume
7
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/MAK pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/MAK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-33.8%
S&P 500 1Y: n/a
3Y total return
-40.4%
S&P 500 3Y: n/a
5Y total return
-74.8%
S&P 500 5Y: n/a
10Y total return
-31.7%
S&P 500 10Y: n/a
Ownership

Who owns ETR/MAK?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.4%
Negative means the company is buying back shares.
Technical

ETR/MAK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.8
Neutral momentum band
Price vs 200-day MA
-7.2%
50/200-day relationship not available
Beta (5Y)
0.09
Less volatile than the market
Sharpe ratio
0.57
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/MAK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/MAK stock rating?

etr/MAK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/MAK analysis?

The full report lives at /stocks/etr/MAK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/MAK?

The latest report frames etr/MAK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/MAK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.